Levosimendan is a calcium sensitizer that demonstrates enhanced myocardial contractility. There is little information concerning the effect of levosimendan on left ventricular tissue parameters and exercise capacity. We evaluated the effects of a 24-h course of levosimendan therapy on cardiac tissue parameters in 30 patients, aged 48-70 years, admitted to our hospital for the management of decompensated heart failure. All patients underwent echocardiographic examination using tissue Doppler imaging (TDI) and a 6-min walk test. Systolic myocardial velocity of the mitral annulus (Sm) was significantly increased in levosimendantreated patients compared with placebotreated patients. There was a positive correlation between Sm and exercise capacity. Levosimendan might be expected to increase cardiac contractile force, especially Sm velocity, in parallel with exercise tolerance. The study has also shown that the progress of ventricular function after levosimendan treatment in patients with exercise intolerance could be monitored effectively by Sm velocity measurements using TDI.
RemmeWJSwedbergK: Taskforce for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J2001; 22: 1527–1560.
2.
McAlisterFATeoKK: The management of congestive heart failure. Postgrad Med J1997; 73: 194–200.
3.
FrancisGS: Neurohumoral activation and progression of heart failure: Hypothetical and clinical considerations. J Cardiovasc Pharmacol1998; 32 (suppl 1): S16–S21.
4.
Steering Committee and Membership of the Advisory Council To Improve Outcomes Nationwide in Heart Failure (ACTION HF): Consensus recommendations for the management of chronic heart failure. Am J Cardiol1999; 83: 1A–38A.
SutherlandGRStewartMJGroundstroemKWMoranCMFlemingAGuell-PerisFJ: Color Doppler myocardial imaging: A new technique for the assessment of myocardial function. J Am Soc Echocardiogr1994; 7: 441–458.
7.
GulatiVKatzWEFollansbeeWPGorcsanJ: Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function. Am J Cardiol1996; 77: 979–984.
8.
SchillerNBShahPMCrawfordMDeMariaADevereuxRFeigenbaumH: Recommendations for quantitation of the left ventricular by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr1989; 2: 358–367.
9.
WahrDWWangYSSchillerNB: Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population. J Am Coll Cardiol1983; 1: 863–868.
10.
KasikciogluEOflazHAkhanHKayseriliogluAMercanogluFUmmanB: Left ventricular remodeling and aortic distensibility in elite power athletes. Heart Vessels2004; 19: 183–188.
11.
GuyattGHSullivanMJThompsonPJFallenELPugsleySOTaylorDW: The six minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J1985; 132: 919–923.
12.
NieminenMSAkkilaJHasenfussGKleberFXLehtonenLAMitrovicV: Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol2000; 36: 1903–1912.
SlawskyMTColucciWSGottliebSSGreenbergBHHaeussleinEHareJ: Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation2000; 102: 2222–2227.
15.
BowmanPHaikalaHPaulR: Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther1999; 288: 316–325.
16.
GruhnNNielsen-KudskJETheilgaardSBangLOlesenSPAldershvileJ: Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol1998; 31: 741–749.
17.
BelardinelliRGeorgiouDCianciGPurcaroA: Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: Effects on functional capacity, quality of life, and clinical outcome. Circulation1999; 99: 1173–1182.
18.
YipGWangMZhangYFungJWHoPYSandersonJE: Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: Time for a redefinition?Heart2002; 87: 121–125.
19.
WitteKKNikitinNPDe SilvaRClelandJGClarkAL: Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure. Heart2004; 90: 1144–1150.
20.
SohnDWChaiIHLeeDJKimHCKimHSOhBH: Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol1997; 30: 474–480.
21.
NaguehSFMiddletonKJKopelenHAZoghbiWAQuinonesMA: Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol1997; 30: 1527–1533.
22.
RumpAFAcarDKlausW: A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol1994; 112: 757–762.
23.
HasenfussGPieskeBCastellMKretschmannBMaierLSJustH: Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation1998; 98: 2141–2147.
24.
EdesIKissEKitadaYPowersFMPappJGKraniasEG: Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res1995; 77: 107–113.
25.
PagelPSMcGoughMFHettrickDALoweDTessmerJPJamaliIN: Levosimendan enhances left ventricular systolic and diastolic function in conscious dogs with pacing-induced cardiomyopathy. J Cardiovasc Pharmacol1997; 29: 563–573.
